What is the starting dose of Mixtard (insulin)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mixtard Starting Dose

For insulin-naive patients with type 2 diabetes, start Mixtard at 10 units per day or 0.1-0.2 units/kg/day, typically divided as two-thirds in the morning and one-third in the evening. 1

Initial Dosing Algorithm

For Insulin-Naive Type 2 Diabetes Patients

  • Begin with 10 units per day OR 0.1-0.2 units/kg body weight per day 2, 1
  • Divide the total daily dose: approximately 2/3 before breakfast and 1/3 before dinner 2, 1
  • For a 70 kg patient, this translates to 7-14 units total daily, giving approximately 5-9 units in the morning and 2-5 units in the evening 3

For Patients Switching from NPH Insulin

  • Calculate total daily dose as 80% of current NPH insulin dose 1
  • This 20% reduction prevents hypoglycemia during the transition 1
  • Split the reduced dose using the same 2/3 morning, 1/3 evening ratio 2

For Type 1 Diabetes Patients

  • Start with 0.5 units/kg/day as total daily dose 1
  • Mixtard provides both basal and prandial coverage in a single injection, though this is less commonly used in type 1 diabetes compared to basal-bolus regimens 2

Titration Strategy

  • Increase dose by 2 units every 3 days if fasting glucose is 140-179 mg/dL 2
  • Increase dose by 4 units every 3 days if fasting glucose is ≥180 mg/dL 2
  • Target fasting plasma glucose of 80-130 mg/dL (4.4-7.2 mmol/L) 2, 1
  • If hypoglycemia occurs without clear cause, reduce the dose by 10-20% immediately 2

Optimal Morning-to-Evening Ratio

Research suggests that starting with a higher morning dose (55:45 to 60:40 ratio) may be more appropriate than an equal split, as patients initially started on 50:50 ratios typically require upward adjustment of their morning dose over time 4. The American Diabetes Association guidelines support individualizing the split based on glucose patterns, with typical ratios of 2/3 morning and 1/3 evening 2.

Special Populations Requiring Dose Adjustment

  • Elderly patients or those with renal impairment: Start at the lower end (0.1 units/kg/day) to minimize hypoglycemia risk 3
  • Patients with severe hyperglycemia (A1C ≥10%, glucose ≥300 mg/dL): Consider higher starting doses of 0.3-0.4 units/kg/day or a basal-bolus regimen instead 2, 5

Critical Pitfalls to Avoid

  • Never convert from NPH to Mixtard on a 1:1 basis—always use 80% of the NPH dose to prevent hypoglycemia 1
  • Do not delay dose titration—adjust every 3 days based on fasting glucose readings rather than waiting weeks between adjustments 2
  • Avoid using premixed insulins like Mixtard in hospitalized patients due to unacceptably high rates of hypoglycemia 5
  • Do not rely on sliding scale insulin alone—scheduled insulin regimens with both basal and prandial components are superior 5

Monitoring Requirements

  • Daily fasting blood glucose monitoring is essential during titration 2, 1
  • Monitor both fasting and postprandial glucose levels to assess regimen effectiveness 1
  • Reassess insulin dose adequacy at every clinical visit 2
  • Continue metformin unless contraindicated when initiating or intensifying insulin therapy 2, 5

References

Guideline

Insulin Mixtard Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Calculating the Dose for Long-Acting Insulin BID

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.